BioNTech (NASDAQ: BNTX) Announces New Co-Founders-Led Firm for Next-Gen mRNA Innovations

March 10, 2026

Expert Analysis BioNTech (NASDAQ: BNTX) is taking a significant strategic step by spinning off a new independent company led by its co-founders. This move is poised to accelerate development of next-generation mRNA technologies by creating a focused entity with dedicated resources, leadership, and funding sources. Industry observers anticipate that this separation could drive more rapid innovation cycles specifically targeting disruptive advances in mRNA therapeutics. By establishing this new company, BioNTech…

Read More >>